Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.07 Million ≈ $-2.21 Million USD) by net assets (CN¥1.74 Billion ≈ $254.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Lianhuan Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Jiangsu Lianhuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Jiangsu Lianhuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600513 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Lianhuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Lianhuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Supervielle S.A. B
BA:SUPV
|
0.176x |
|
Companhia de Saneamento do Paraná - SANEPAR
SA:SAPR3
|
0.414x |
|
Golden Entertainment Inc
NASDAQ:GDEN
|
0.062x |
|
Neto Malinda
TA:NTML
|
-0.090x |
|
UBISOFT ENTMT ADR 1/5
F:UEN0
|
N/A |
|
Lg Electronics Pref
KO:066575
|
0.061x |
|
Pakuwon Jati Tbk
JK:PWON
|
0.026x |
|
Surge Energy Inc.
TO:SGY
|
0.086x |
Annual Cash Flow Conversion Efficiency for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.58 Billion ≈ $230.80 Million |
CN¥10.77 Million ≈ $1.58 Million |
0.007x | -93.56% |
| 2023-12-31 | CN¥1.52 Billion ≈ $222.03 Million |
CN¥160.70 Million ≈ $23.52 Million |
0.106x | +17.35% |
| 2022-12-31 | CN¥1.41 Billion ≈ $206.87 Million |
CN¥127.59 Million ≈ $18.67 Million |
0.090x | -16.44% |
| 2021-12-31 | CN¥1.28 Billion ≈ $187.44 Million |
CN¥138.34 Million ≈ $20.24 Million |
0.108x | +38.86% |
| 2020-12-31 | CN¥1.18 Billion ≈ $172.97 Million |
CN¥91.94 Million ≈ $13.45 Million |
0.078x | +954.26% |
| 2019-12-31 | CN¥1.08 Billion ≈ $158.63 Million |
CN¥-9.87 Million ≈ $-1.44 Million |
-0.009x | +90.63% |
| 2018-12-31 | CN¥946.61 Million ≈ $138.52 Million |
CN¥-92.00 Million ≈ $-13.46 Million |
-0.097x | -2447.48% |
| 2017-12-31 | CN¥878.23 Million ≈ $128.51 Million |
CN¥3.64 Million ≈ $532.06K |
0.004x | -95.13% |
| 2016-12-31 | CN¥827.25 Million ≈ $121.05 Million |
CN¥70.28 Million ≈ $10.28 Million |
0.085x | +5.99% |
| 2015-12-31 | CN¥774.88 Million ≈ $113.39 Million |
CN¥62.12 Million ≈ $9.09 Million |
0.080x | -49.91% |
| 2014-12-31 | CN¥434.25 Million ≈ $63.54 Million |
CN¥69.50 Million ≈ $10.17 Million |
0.160x | +73.13% |
| 2013-12-31 | CN¥402.11 Million ≈ $58.84 Million |
CN¥37.17 Million ≈ $5.44 Million |
0.092x | +91.22% |
| 2012-12-31 | CN¥350.42 Million ≈ $51.28 Million |
CN¥16.94 Million ≈ $2.48 Million |
0.048x | -34.00% |
| 2011-12-31 | CN¥327.61 Million ≈ $47.94 Million |
CN¥24.00 Million ≈ $3.51 Million |
0.073x | +168.56% |
| 2010-12-31 | CN¥308.95 Million ≈ $45.21 Million |
CN¥8.43 Million ≈ $1.23 Million |
0.027x | -42.05% |
| 2009-12-31 | CN¥293.89 Million ≈ $43.01 Million |
CN¥13.83 Million ≈ $2.02 Million |
0.047x | -23.99% |
| 2008-12-31 | CN¥281.68 Million ≈ $41.22 Million |
CN¥17.44 Million ≈ $2.55 Million |
0.062x | +108.09% |
| 2007-12-31 | CN¥269.97 Million ≈ $39.51 Million |
CN¥8.03 Million ≈ $1.18 Million |
0.030x | -23.97% |
| 2006-12-31 | CN¥259.20 Million ≈ $37.93 Million |
CN¥10.14 Million ≈ $1.48 Million |
0.039x | +162.08% |
| 2005-12-31 | CN¥255.97 Million ≈ $37.46 Million |
CN¥3.82 Million ≈ $559.35K |
0.015x | +10.21% |
| 2004-12-31 | CN¥250.42 Million ≈ $36.64 Million |
CN¥3.39 Million ≈ $496.50K |
0.014x | +125.29% |
| 2003-12-31 | CN¥246.22 Million ≈ $36.03 Million |
CN¥-13.19 Million ≈ $-1.93 Million |
-0.054x | -123.77% |
| 2002-12-31 | CN¥85.26 Million ≈ $12.48 Million |
CN¥19.22 Million ≈ $2.81 Million |
0.225x | -- |
About Jiangsu Lianhuan Pharmaceutical Co Ltd
Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprili… Read more